CLYM

CLIMB BIO, INC.

CLYM · CIK 1768446 · Annual (10-K) · Last 4 years

Financial Trends

Revenue
20212024
Net Income−$74M
20212024
Operating CF−$16M
20212024
Free Cash Flow
20212024

Income Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕
Revenue————
Cost of Revenue————
Gross Profit————
R&D Expense$0.0B$0.0B$0.0B$0.0B
SG&A Expense————
Operating Income$-0.1B$-0.0B$-0.0B$-0.0B
Net Income$-0.1B$-0.0B$-0.0B$-0.0B
EPS (Basic)$-1.53$-1.30$-1.72—
EPS (Diluted)$-1.53$-1.30$-1.72—

Balance Sheet

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕
Total Assets$0.2B$0.1B$0.1B$0.2B
Current Assets$0.2B$0.1B$0.1B$0.1B
Cash & Equivalents$0.1B$0.1B$0.0B$0.0B
Total Liabilities$0.0B$0.0B$0.0B$0.0B
Current Liabilities$0.0B$0.0B$0.0B$0.0B
Stockholders' Equity$0.2B$0.1B$0.1B$0.2B

Cash Flow Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕
Operating Cash Flow$-0.0B$-0.0B$-0.0B$-0.0B
Investing Cash Flow$-0.1B$0.1B$0.0B$-0.1B
Capital Expenditures————
Financing Cash Flow$0.1B$0.0B$0.0B$0.2B
← Companies